Prostate Cancer Clinical Trials in Boston

Showing 101-120 of 288 trials

Jump: MR Simulation For Radiation Therapy Master Protocol

NCT04545957

This is a master protocol for a prospective Phase I-II study evaluating feasibility and efficacy of incorporating magnetic resonance imaging (MRI) simulation into the planning of radiation treatments.

Prostate CancerRecurrent AdenocarcinomaLiver Cancer+1 more

Brigham and Women's Hospital86 participantsStarted Oct 2020

Boston, Massachusetts, United States • Boston, Massachusetts, United States

COMPLETEDPhase 1< 1 mile

Trial of ARV-110 and Abiraterone in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

NCT05177042

Phase 1b study to assess the combination of ARV-110 and abiraterone in patients with metastatic prostate cancer with rising PSA values on abiraterone.

Prostate Cancer Metastatic

Arvinas Androgen Receptor, Inc.45 participantsStarted Feb 2022

Santa Monica, California, United States • New Haven, Connecticut, United States • Fort Myers, Florida, United States +15 more locations

Jump: MR Simulation For Radiation Therapy Master Protocol

Trial of ARV-110 and Abiraterone in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

Prostate Cancer Trials in Other Cities

Hypofractionated Stereotactic Body Radiation Therapy as a Boost to the Prostate

Neoadjuvant And Adjuvant Abiraterone Acetate + Apalutamide Prostate Cancer Undergoing Prostatectomy

Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer

Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

Experiment to Assess Preferences for Novel Hormonal Therapy and Androgen-deprivation Therapy in Prostate Cancer Patients

Continued Access of Focal MR-Guided Focused Ultrasound for Localized Intermediate Risk Prostate Lesions

Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors

Aberrant Gene Expression Prostate Carcinoma

A Study of Copanlisib Combined With Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer

A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors

A Study of Nivolumab or Placebo in Combination With Docetaxel in Men With Advanced Castration-resistant Prostate Cancer

LTFU for All Cell and Gene Therapy Studies

Trial of LAVA-1207 in Patients With Therapy Refractory Metastatic Castration Resistant Prostate Cancer (mCRPC) Resistant Prostate Cancer

The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)

PSMA PET/CT Guided Intensification of Therapy in Patients at Risk of Advanced Prostate Cancer

MGC018 With or Without MGA012 in Advanced Solid Tumors

Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer

Other Conditions in Boston